We provide treatments for a wide range of respiratory infections and diseases, based on our proprietary formulation and systems

Pipeline

AIT has acquired positive clinical data in previous clinical trials. AIT is currently preparing for Phase II clinical trial for CF exacerbation, CF NTM and COPD, in addition to a phase III clinical trial for RSV (bronchiolitis).

ProductIndicationPre-ClinicalPhase 1Phase 2Phase 3Status
RSV
RSV (Bronchiolitis)
First Phase 3 trial to be completed in 2017
CF NTM
Non Tuberculosis Mycobacterium (NTM) & CF
Phase 2 to be completed in 2017
COPD smallCOPD
Chronic Obstructive Pulmonary Disease
Phase 2 to be completed in 2018
CF Exacerbation
Cystic Fibrosis (CF) Exacerbation
Phase 2 to be completed in 2017